2011
DOI: 10.1111/j.1399-3062.2011.00657.x
|View full text |Cite
|
Sign up to set email alerts
|

Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia

Abstract: A 38-year-old patient with systemic lupus erythematosus presented with pulmonary infiltrates and hypoxemia for several months following immunodepleting autologous hematopoietic stem cell transplantation. She was treated for influenza, which was isolated repeatedly from ororpharynx and bronchoalveolar lavage fluids, and later empirically for lupus pneumonitis, but expired 6 months after transplant. Autopsy findings failed to show influenza in the lungs or lupus pneumonitis. A novel generic PCR-based assay using… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
33
0
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
2
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(34 citation statements)
references
References 20 publications
0
33
0
1
Order By: Relevance
“…Previous studies have demonstrated that HCoV is now the second most common virus identified from the upper respiratory tract in hematopoietic cell transplant (HCT) recipients [8]. Cases of fatal pneumonia related to HCoV without copathogens have also been reported mainly in HCT populations [9][10][11][12]. Two previous studies describe the possible role of HCoV in LRTD; however, these studies included only limited numbers of HCT recipients and patients with hematologic malignancy (HM), and outcome analyses could not be done [13,14].…”
mentioning
confidence: 99%
“…Previous studies have demonstrated that HCoV is now the second most common virus identified from the upper respiratory tract in hematopoietic cell transplant (HCT) recipients [8]. Cases of fatal pneumonia related to HCoV without copathogens have also been reported mainly in HCT populations [9][10][11][12]. Two previous studies describe the possible role of HCoV in LRTD; however, these studies included only limited numbers of HCT recipients and patients with hematologic malignancy (HM), and outcome analyses could not be done [13,14].…”
mentioning
confidence: 99%
“…Clinical studies have shown that coronavirus infection severity was linked to patient health status and an immunocompromised state carried an increased risk of death 6,7 . Clinical studies have shown that coronavirus infection severity was linked to patient health status and an immunocompromised state carried an increased risk of death 6,7 .…”
Section: Discussionmentioning
confidence: 99%
“…It is widely used to amplify minute quantities of biologic materials so as to provide adequate specimens for laboratory study. Owing to its large range of applications, high sensitivity and high sequence specificity, the PCR-based method has become a routine and reliable technique for detecting coronaviruses [6,7]. Generally, coronavirus RNA is transferred into cDNA by reverse transcription.…”
Section: Pcr-based Methodsmentioning
confidence: 99%